We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Aisling Capital Management
New York
$7.14M
VP
2
venBio Partners
California
$6.57M
QUSVM
3
Qiming U.S. Ventures Management
Washington
$5.97M
BI
4
BVF Inc
California
$5.83M +$2.81M +700,500 +43%
CAM
5
Cormorant Asset Management
Massachusetts
$5M
DCM
6
Driehaus Capital Management
Illinois
$3.96M -$1.65M -410,951 -21%
Janus Henderson Group
7
Janus Henderson Group
$2.8M -$118K -29,438 -3%
SB
8
Samsara BioCapital
California
$2.35M
BC
9
Boxer Capital
California
$2.2M
TCM
10
TCG Crossover Management
California
$1.4M
VC
11
Vivo Capital
California
$1.25M
Vanguard Group
12
Vanguard Group
Pennsylvania
$948K -$18.7K -4,660 -1%
SCM
13
Sio Capital Management
New York
$907K +$440K +109,731 +44%
CC
14
Caxton Corporation
New Jersey
$172K +$52K +12,980 +23%
BCM
15
Bridgeway Capital Management
Texas
$142K +$227K +56,500 New
MAM
16
Marquette Asset Management
Minnesota
$98K +$120K +29,945 +333%
BlackRock
17
BlackRock
New York
$96K +$55.9K +13,936 +57%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$66K +$21K +5,245 +25%
Renaissance Technologies
19
Renaissance Technologies
New York
$64K +$35.3K +8,800 +53%
B
20
Bailard
California
$59K +$94.2K +23,500 New
State Street
21
State Street
Massachusetts
$47K
KCM
22
Kennedy Capital Management
Missouri
$35K -$5.83K -1,455 -9%
LCM
23
Lynx1 Capital Management
Puerto Rico
$25K +$40.1K +10,000 New
Morgan Stanley
24
Morgan Stanley
New York
$16K -$6.28K -1,566 -20%
TRCT
25
Tower Research Capital (TRC)
New York
$5K +$4.25K +1,060 +107%